Holcenberg JS - Search Results

1

Phase I and clinical pharmacological study of mercaptopurine administered as a prolonged intravenous infusion.

Zimm S, Ettinger LJ, Holcenberg JS, Kamen BA, Vietti TJ, Belasco J, Cogliano-Shutta N, Balis F, Lavi LE, Collins JM, et al. Zimm S, et al. Among authors: holcenberg js. Cancer Res. 1985 Apr;45(4):1869-73. Cancer Res. 1985. PMID: 4038917

2

Pediatric phase I trial and pharmacokinetic study of trimetrexate.

Balis FM, Patel R, Luks E, Doherty KM, Holcenberg JS, Tan C, Reaman GH, Belasco J, Ettinger LJ, Zimm S, et al. Balis FM, et al. Among authors: holcenberg js. Cancer Res. 1987 Sep 15;47(18):4973-6. Cancer Res. 1987. PMID: 2957048

3

Pediatric phase I trial and pharmacokinetic study of tiazofurin (NSC 286193).

Balis FM, Lange BJ, Packer RJ, Holcenberg JS, Ettinger LJ, Sallan SE, Heideman RL, Zimm S, Smithson WA, Cogliano-Shutta NA, et al. Balis FM, et al. Among authors: holcenberg js. Cancer Res. 1985 Oct;45(10):5169-72. Cancer Res. 1985. PMID: 4027992

4

Phase I trial of mitoxantrone in children.

Ungerleider RS, Pratt CB, Vietti TJ, Holcenberg JS, Kamen BA, Glaubiger DL, Cohen LF. Ungerleider RS, et al. Among authors: holcenberg js. Cancer Treat Rep. 1985 Apr;69(4):403-7. Cancer Treat Rep. 1985. PMID: 3857968

5

Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients.

Avramis VI, Champagne J, Sato J, Krailo M, Ettinger LJ, Poplack DG, Finkelstein J, Reaman G, Hammond GD, Holcenberg JS. Avramis VI, et al. Among authors: holcenberg js. Cancer Res. 1990 Nov 15;50(22):7226-31. Cancer Res. 1990. PMID: 1699658 Clinical Trial.

6

Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study.

Adamson PC, Balis FM, Arndt CA, Holcenberg JS, Narang PK, Murphy RF, Gillespie AJ, Poplack DG. Adamson PC, et al. Among authors: holcenberg js. Cancer Res. 1991 Nov 15;51(22):6079-83. Cancer Res. 1991. PMID: 1933871 Clinical Trial.

7

The effect of methotrexate on the bioavailability of oral 6-mercaptopurine.

Balis FM, Holcenberg JS, Zimm S, Tubergen D, Collins JM, Murphy RF, Gilchrist GS, Hammond D, Poplack DG. Balis FM, et al. Among authors: holcenberg js. Clin Pharmacol Ther. 1987 Apr;41(4):384-7. doi: 10.1038/clpt.1987.45. Clin Pharmacol Ther. 1987. PMID: 3470165

8

A rapid and sensitive high-performance liquid chromatographic assay for 6-mercaptopurine metabolites in red blood cells.

Lavi LE, Holcenberg JS. Lavi LE, et al. Among authors: holcenberg js. Anal Biochem. 1985 Feb 1;144(2):514-21. doi: 10.1016/0003-2697(85)90148-4. Anal Biochem. 1985. PMID: 4039541

9

High-dose trimetrexate and minimal-dose leucovorin: a case for selective protection?

Hum M, Holcenberg JS, Tkaczewski I, Weaver JW, Wilson J, Kamen BA. Hum M, et al. Among authors: holcenberg js. Clin Cancer Res. 1998 Dec;4(12):2981-4. Clin Cancer Res. 1998. PMID: 9865909 Clinical Trial.

10

Phase I study of ICRF-187 in pediatric cancer patients and comparison of its pharmacokinetics in children and adults.

Holcenberg JS, Tutsch KD, Earhart RH, Ungerleider RS, Kamen BA, Pratt CB, Gribble TJ, Glaubiger DL. Holcenberg JS, et al. Cancer Treat Rep. 1986 Jun;70(6):703-9. Cancer Treat Rep. 1986. PMID: 3089595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters